Researchers are working to track the genes that are known to be associated with Alzheimer’s disease. A new database known as the International Genomics of Alzheimer’s Project (IGAP) now allows researchers around the globe to collaborate on identifying and mapping the genes. Fifteen nations have participated in the project with a staggering 74,076 patients.
While some researchers will focus on genes implicated in late-onset Alzheimer’s disease, others will hone in on genes linked to the progression of the illness. The goal of the project is to identify risk-factors, possible prevention, and potential avenues for treatment. Already, the study is identifying genes that were not previously associated with Alzheimer’s disease.
This study could provide new opportunities for more precise drug protocols as well as other treatment options for treating dementia. At present, medication treats the side effects of Alzheimer’s without targeting the disease itself. This collaborative research has the potential to change the way the medical community diagnoses and treats Alzheimer’s disease.
